Cargando…

Microbiological and Clinical Aspects of Actinomyces Infections: What Have We Learned?

Detalles Bibliográficos
Autores principales:	Urbán, Edit, Gajdács, Márió
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913296/ https://www.ncbi.nlm.nih.gov/pubmed/33546209 http://dx.doi.org/10.3390/antibiotics10020151

Ejemplares similares

Microbiological and Clinical Aspects of Cervicofacial Actinomyces Infections: An Overview
por: Gajdács, Márió, et al.
Publicado: (2019)

The Pathogenic Role of Actinomyces spp. and Related Organisms in Genitourinary Infections: Discoveries in the New, Modern Diagnostic Era
por: Gajdács, Márió, et al.
Publicado: (2020)

Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology?
por: Gajdács, Márió, et al.
Publicado: (2017)

The incidence of anaerobic bacteria in adult patients with chronic sinusitis: A prospective, single-centre microbiological study
por: URBÁN, EDIT, et al.
Publicado: (2020)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

COVID-19: what have we learned?
por: Ho, Yeh-Li, et al.
Publicado: (2020)

Ebola, epidemics, and ethics - what we have learned
por: Donovan, G Kevin
Publicado: (2014)

ISAR-REACT 5 — What have we learned?
por: Kubica, Jacek, et al.
Publicado: (2019)

The COVID-19 challenge. What have we learned?
por: Ceccato, Adrian, et al.
Publicado: (2022)

Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study
por: Gajdács, Márió, et al.
Publicado: (2019)

Resistance Trends and Epidemiology of Citrobacter-Enterobacter-Serratia in Urinary Tract Infections of Inpatients and Outpatients (RECESUTI): A 10-Year Survey
por: Gajdács, Márió, et al.
Publicado: (2019)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

COVID-19: What have we learned? What are the public health challenges?
por: Zeegers Paget, Dineke, et al.
Publicado: (2021)

Actinomyces species: A Danish Survey on Human Infections and Microbiological Characteristics
por: Hansen, J.M, et al.
Publicado: (2009)

What have we learned ventilating COVID-19 patients?
por: Trahtemberg, Uriel, et al.
Publicado: (2020)

Caffeine and Doping—What Have We Learned since 2004
por: Diel, Patrick
Publicado: (2020)

Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature
por: Urbán, Edit, et al.
Publicado: (2020)

Special Issue: “Fungi: What Have We Learned from Omics?”
por: Esteves, Ana Cristina
Publicado: (2022)

What have we learned in the 3 years of the COVID-19 pandemic?
por: Maisch, Bernhard, et al.
Publicado: (2023)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary
por: Gajdács, Márió, et al.
Publicado: (2019)

Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot
por: Gajdács, Márió, et al.
Publicado: (2019)

A 10-year single-center experience on Stenotrophomonas maltophilia resistotyping in Szeged, Hungary
por: GAJDÁCS, MÁRIÓ, et al.
Publicado: (2020)

Relevance of anaerobic bacteremia in adult patients: A never-ending story?
por: GAJDÁCS, MÁRIÓ, et al.
Publicado: (2020)

Eating Disorders in the Era of the COVID-19 Pandemic: What Have We Learned?
por: Monteleone, Palmiero
Publicado: (2021)

Small, but smelly: the importance of Solobacterium moorei in halitosis and other human infections
por: Barrak, Ibrahim, et al.
Publicado: (2020)

COVID-19 and heart disease in children: What have we learned?
por: Kadiyani, Lamk, et al.
Publicado: (2023)

Editorial of Special Issue “The COVID-19 Pandemic and Bacterial Infections: Microbiological and Clinical Aspects”
por: Di Pilato, Vincenzo, et al.
Publicado: (2023)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Review and publication of protocol submissions to Trials – what have we learned in 10 years?
por: Li, Tianjing, et al.
Publicado: (2016)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

The adverse reactions to vaccines practice parameter 10 years on—what have we learned?
por: Wolfson, Anna R.
Publicado: (2022)

Nursing in the context of the COVID-19 pandemic: what lessons have we learned?1
por: Barbosa, Dulce Aparecida, et al.
Publicado: (2022)

Diagnosis of COVID-19. What have we learned after two years of the pandemic?
por: Iñigo, Melania, et al.
Publicado: (2022)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Oh, the Lessons We Have Learned!
por: Zimmerman, Karen G., et al.
Publicado: (2017)

Noncontiguous finished genome sequences and descriptions of Actinomyces ihuae, Actinomyces bouchesdurhonensis, Actinomyces urinae, Actinomyces marseillensis, Actinomyces mediterranea and Actinomyces oralis sp. nov. identified by culturomics
por: Mbogning Fonkou, M.D., et al.
Publicado: (2018)

Association between Biofilm-Production and Antibiotic Resistance in Uropathogenic Escherichia coli (UPEC): An In Vitro Study
por: Behzadi, Payam, et al.
Publicado: (2020)

Proceedings of the 13th international transplantation symposia: mTOR-inhibition: what have we learned and how so we best apply the learning
por: Jardine, Alan G.
Publicado: (2015)

SARS: What have we learned?
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_03fhkgglqj73d7l4pd3a437fe1